KF
CYTK icon

Kopp Funds’s Cytokinetics CYTK Stock Holding History

Kopp Funds’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$176K Buy
+27,001
New +$177K 0.08% 61

Other funds holding CYTK

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LPLP
Lansdowne Partners Limited Partnership London, United Kingdom $11.9B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
IIM
Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return

Kopp Funds's CYTK Position: Q4 2013 in Review

Kopp Funds opened a new position in Cytokinetics (CYTK) in Q4 2013: 27,001 shares worth $176K. The stake represents 0.08% of the portfolio and ranks #61 among its holdings.

95 funds tracked by Wall St. Rank hold CYTK as of Q4 2013.

  • Kopp Funds held 27,001 shares of Cytokinetics worth $176K as of Q4 2013.
  • Cytokinetics was a new Kopp Funds position in Q4 2013.
  • Cytokinetics made up 0.08% of Kopp Funds's portfolio in Q4 2013, its #61 holding.
  • 95 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2013.

Based on Kopp Funds's 13F filing for Q4 2013, filed 21 Jan 2014.